Article

Germline and Tumor BRCA1/2 Pathogenic Variants in Chinese Triple-negative Breast Carcinomas

2021-03-11

Abstract excerpt

<title>Abstract</title> <p>PurposeThe cost-effectiveness of BRCA1/2 screening for all newly diagnosed breast cancer remains controversial with respect to standard treatment. Further evidences that include incidence and outcome of BRCA1/2 pathogenic variants (PV) screened based on age or family history (FH) are needed to fully justify this conclusion. We aimed to investigate germline and tumor BRCA1/2 PV based on...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: aad334d5-0095-50ba-a254-8055d7421368
DOI: 10.21203/rs.3.rs-262082/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Germline and Tumor BRCA1/2 Pathogenic Variants in Chinese Triple-negative Breast CarcinomasDOI 10.21203/rs.3.rs-262082/v1Read

Germline and tumor BRCA1/2 pathogenic variants in Chinese triple-negative breast carcinomas.Semantic proximity Read

Prevalence of BRCA1 and BRCA2 pathogenic variants in 8627 unselected patients with breast cancer: stratification of age at diagnosis, family history and molecular subtype.Semantic proximity Read

Prevalence and Prognostic Role of BRCA1/2 Variants in Unselected Chinese Breast Cancer Patients.Semantic proximity Read

Analysis of BRCA1/2 mutation spectrum and prevalence in unselected Chinese breast cancer patients by next-generation sequencing.Semantic proximity Read

Germline and Somatic BRCA1/2 Mutations in 172 Chinese Women With Epithelial Ovarian CancerSemantic proximity Read

BRCA1 and BRCA2 germline mutations in Chinese Hakka breast cancer patients.Semantic proximity Read

Characteristics of breast cancer patients tested for germline BRCA1/2 mutations by next-generation sequencing in Ramathibodi Hospital, Mahidol UniversitySemantic proximity Read

The spectrum of BRCA mutations and characteristics of BRCA-associated breast cancers in China: Screening of 2,991 patients and 1,043 controls by next-generation sequencing.Semantic proximity Read

Prevalence and Clinical Impact of Germline Pathogenic Variants in Breast Cancer Susceptibility Genes among Chinese Male Patients with Breast CancerSemantic proximity Read

Prevalence and Spectrum of BRCA1/2 Germline Mutations in Women with Breast Cancer in China Based on Next-Generation Sequencing.Semantic proximity Read

Comprehensive analysis of BRCA1 and BRCA2 germline mutations in a large cohort of 5931 Chinese women with breast cancer.Semantic proximity Read

Characteristics of breast cancer patients tested for germline BRCA1/2 mutations by next-generation sequencing in Ramathibodi Hospital, Mahidol University.Semantic proximity Read